Complete sequencing of a genetic polymorphism in NAT2 in the Korean population

Clinical Chemistry

Volumn 48, Issue 5, 2002, Pages 775-777

  Lee, Soo Youn ^a   Lee, Kyung A ^a   Ki, Chang Seok ^a   Kwon, O Jung ^a   Ho, Joong Kim ^a   Man, Pyo Chung ^a   Gee, Young Suh ^a   Kim, Jong Won ^a  

^a Samsung Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLISONIAZID; ACYLTRANSFERASE; ARYLAMINE ACETYLTRANSFERASE; ISONIAZID; UNCLASSIFIED DRUG;

ACETYLATOR PHENOTYPE; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG ACETYLATION; DRUG BLOOD LEVEL; DRUG URINE LEVEL; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE PHENOTYPE CORRELATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; NORMAL HUMAN; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; SEQUENCE ANALYSIS; SOUTH KOREA;

EID: 0036226585     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.5.775     Document Type: Article

References (13)

1. Distribution and concordance of N-acetyltransferase genotype and phenotype in an American population
2. Human acetyltransferase polymorphisms
3. Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: Correlation with phenotypic activity
4. Genotyping of the polymorphic N-acetyltransferase (NAT2*) gene locus in two native African populations
5. High-performance liquid chromatographic determination of isoniazid, acetylisoniazid and hydrazine in biological fluids
6. Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, blacks, Hispanics, and whites: Application to metabolic epidemiology
7. Comparison of isoniazid phenotyping methods and acetylator distribution in 43 native Korean subjects
8. CYP1A2 activity as a risk factor for bladder cancer
9. A case-control study on the effects of the genetic polymorphisms of N-acetyltransferase 2 and glutathione S-transferase μ and θ on the risk of bladder cancer
10. Novel human N-acetyltransferase 2 alleles that differ in mechanism for slow acetylator phenotype
11. The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis
12. Relationship between human genotype and phenotype of N-acetyltransferase (NAT2) as estimated by discriminant analysis and multiple linear regression: 1. Genotype and N-acetylation in vivo